Autism Socks
Johnson & Johnson Halted in US

Opinion Letter: Doubts about the vaccine shouldn’t be disparaged

Look before you leapThanks to loyal AofA reader, contributor and donor (xox) Josh Mazer for sharing his most recent opinion letter from Maryland's Capital Gazette.

By Capital Gazette letters
Capital Gazette |
Apr 09, 2021 at 3:00 PM
Vaccine doubts

Letters: Doubts about the vaccine shouldn’t be disparaged

Iris Krasnow’s disparaging, vaccine-hesitant column about frontline health care at Anne Arundel Medical Center will not help increase vaccine uptake (The Capital, April 4). Addressing their concerns might. Ironically, the “first, do no harm’ standard Krasnow demands shows the refusers may be on firm scientific and medical grounds.

Reported links to blood clotting disorders have caused numerous European nations, Canada and Australia, to suspend or restrict the use of the AstraZeneca shot. A Journal of the American Medical Association research letter on March 8 found allergic reactions occurred in 2.10% of 64,900 employees who got the vaccine at Mass General Bingham hospital, and “severe reactions consistent with anaphylaxis occurred at a rate of 2.47 per 10,000 vaccinations.”

Some school districts across the country have temporarily closed due to mass absenteeism after school personnel was vaccinated.

Dr. Gregory Michael died from acute immune thrombocytopenia 16 days after receiving a vaccine. Dr. Jerry L. Spivak, an expert on blood disorders at Johns Hopkins University, said, “I think it is a medical certainty that the vaccine was related” but also called it likely a very rare occurrence.

In Maryland, the federal Vaccine Adverse Effects Reporting System shows 28 deaths reported after COVID shots. Correlation does not prove causation, yet the data is concerning nonetheless.

FDA clinical studies show vaccinated people still acquire and may spread the virus. Hundreds of “breakthrough” cases are now reported in vaccinated people across the nation, something that can happen with any vaccines used on a mass scale.

I personally am grateful for the COVID vaccination. I support everyone’s choice. Divisive rhetoric targeting health care workers is counterproductive. These people are risking their lives for us. Listening with an open mind to their concerns will bring us together as a community, and help make us all safer.

Josh Mazer


Bob Moffit

I think I read the USA has halted the J&J vaccine for the same fears of "blood clots" reported by AstraZenaca shot .. also learning more and more covid victims who had been fully vaccinated weeks before contracting covid.

If EITHER of those dire possibilities hold true for a sizeable number of VACCINATED population .. the idea that our lives will EVER RETURN TO NORMAL IS HIGHLY UNLIKELY.


J&J's kool aid is being pulled from the market, thank goodness.

The two leading federal public health agencies called for an immediate pause in the use of the Johnson & Johnson JNJ, +0.24% COVID-19 vaccine on Tuesday, after six recipients in the U.S. developed a rare disorder involving blood clots within six to 13 days after being vaccinated. The news was first reported by the New York Times, citing officials briefed on the decision. The U.S. Food and Drug Administration and Centers for Disease Control and Prevention said all six were women aged between 18 and 48 and emphasized that the adverse events appear to be "extremely rare." "In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia)," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research and Dr. Anne Schuchat, Principal Deputy Director of the CDC said in a statement. So far, nearly 7 million Americans have received J&J shots, and about 9 million more have been delivered to states, CDC data shows. Scientists from the FDA and CDC will jointly investigate possible links between the vaccine and the clotting disorder and determine whether it should continue to be used or be limited. An emergency meeting of the CDC's outside advisory committee has been scheduled for Wednesday. "Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution," said the statement. Regulators in Europe are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca PLC AZN, -1.04% AZN, -0.76% and Oxford University researchers. J&J shares slid 3.3% premarket, but are up 2.7% in the year to date through Monday, while the Dow Jones Industrial Average DJIA, -0.16% has gained 10.3%.

Laura Hayes

3-minute video about the new “vaccines”, utilizing CDC’s latest answers about them. Good one to share.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name and email address are required. Email address will not be displayed with the comment.)